NEWS
Our Latest News
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
Private equity healthcare specialist ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials
May
18,
2020
Growth investment is set to accelerate Polyplus’ expansion in partnership with Warburg Pincus and ARCHIMED
April
29,
2020
ARCHIMED’s DHG completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB
March
3,
2020
ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge
December
12,
2019
368